SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
2020 · Journal of Translational Medicine · 197 citations
https://doi.org/10.1186/s12967-020-02392-y
E
Emanuele Marra
Takeda (Italy)(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
1.2K
Citations
22
h-index
29
i10-index
Emanuele Marra is an academic researcher from Takeda (Italy). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Monoclonal and Polyclonal Antibodies Research & Immunotherapy and Immune Responses. The author has an h-index of 22, co-authored 56 publications.
ORCID: 0000-0001-7492-5514Papers by this author
worksNovel anti‐ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors
2011 · Journal of Cellular Physiology · 32 citations
https://doi.org/10.1002/jcp.24037
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy
2022 · Molecular Therapy · 0 citations
https://doi.org/10.1016/j.ymthe.2022.02.013
Immunotherapy Bridge 2021 and Melanoma Bridge 2021: meeting abstracts
2022 · Journal of Translational Medicine · 0 citations
https://doi.org/10.1186/s12967-022-03290-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat